← back to search

Jennifer C. Lovejoy

ProNAi Therapeutics (United States) · US
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Diet and metabolism studies, Metabolomics and Mass Spectrometry Studies, Obesity, Physical Activity, Diet, and Adipose Tissue and Metabolism.
h-index
49
citations
10,032
works
151
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure
Diabetes Care 2024cited by 10position: middledoi
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
Diabetes Care 2022cited by 29position: middledoi
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Scientific Reports 2022cited by 27position: middledoi
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
Nature Metabolism 2021cited by 659position: middledoi
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Diabetes Care 2021cited by 98position: middledoi
Manifestations of Alzheimer’s Disease Genetic Risk in the Blood: A Cross-Sectional Multi-Omic Analysis in Healthy Adults Aged 18-90+
Research Square 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nathan D. Price · Buck Institute for Research on Aging2 papers (2021–2021)Andrew T. Magis · University of California, San Francisco2 papers (2021–2021) · 2 papers (2021–2021)John C. Earls · Buck Institute for Research on Aging2 papers (2021–2021)Christian Diener · Medical University of Graz1 papers (2021–2021)Gustavo Glusman · Seattle University1 papers (2021–2021)Jodi Lapidus · Portland State University1 papers (2021–2021)Eric Orwoll · University of Portland1 papers (2021–2021)Jane A. Cauley · University of Pittsburgh1 papers (2021–2021)Tomasz Wilmanski · Center for Cancer Research1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Nancy E. Lane · University of California, Davis1 papers (2021–2021)Lara M. Mangravite · Wake Forest University1 papers (2021–2021)Anat Zimmer · Seattle University1 papers (2021–2021)Adam C. Naj · California University of Pennsylvania1 papers (2021–2021)Joseph M. Zmuda · University of Pittsburgh1 papers (2021–2021)Todd E. Golde · Emory University1 papers (2021–2021) · 1 papers (2021–2021)Deborah M. Kado · Stanford Health Care1 papers (2021–2021)